Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension (2010)
- Authors:
- USP affiliated authors: FAZAN JÚNIOR, RUBENS - FMRP ; ROSSI, MARCOS ANTONIO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; GERLACH, RAQUEL FERNANDA - FORP
- Unidades: FMRP; FORP
- Subjects: HIPERTROFIA VENTRICULAR ESQUERDA; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2010
- Source:
- Título: Journal of Cardiac Failure
- ISSN: 1071-9164
- Volume/Número/Paginação/Ano: v. 16, n. 7, p. 599-608, 2010
-
ABNT
RIZZI, Élen et al. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure, v. 16, n. 7, p. 599-608, 2010Tradução . . Acesso em: 27 jan. 2026. -
APA
Rizzi, É., Castro, M. M., Prado, C. M., Silva, C. A., Fazan Junior, R., Rossi, M. A., et al. (2010). Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure, 16( 7), 599-608. -
NLM
Rizzi É, Castro MM, Prado CM, Silva CA, Fazan Junior R, Rossi MA, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure. 2010 ; 16( 7): 599-608.[citado 2026 jan. 27 ] -
Vancouver
Rizzi É, Castro MM, Prado CM, Silva CA, Fazan Junior R, Rossi MA, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure. 2010 ; 16( 7): 599-608.[citado 2026 jan. 27 ] - Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes
- TGF-Beta and matrix metalloproteinases upregulation contribute to cardiac alterations in 2K1C hypertension via oxidative stress
- Imbalance between matrix metalloproteinases and tissue inhibtor of metalloproteinases in hypertensive vascular remodeling
- Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy
- Imbalance between MMP-2 and TIMP-4 associated with oxidative stress contributes to temporal renovascular hypertension-induced cardiac hypertrophy
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
